Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an inactivated varicella-zoster vaccine for prevention of herpes zoster and related complications in hematopoietic cell transplant reci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Inactivated Varicella-zoster Vaccine (VZV)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster | Phase 3 | Status: COMPLETED | Results posted: 2018-07-02